Forum Archive Index - December 2002

["G Stolwyk" <stolwyk@wave.co.nz>]

NRT has commenced Trials on Cancer patients-Leukemia, Cervical and Ovarian.

 

These Patients were treated with two methods previously but these failed and now NRT (NOVOGEN) had these patients selected to undergo a Phenoxodiol treatment immediately followed by a mixture of Pheno. and Cisplatin. 

 

The patients have advanced cancers and some have only 4 to 6 months left to live. So, NRT has significant hurdles to overcome.

 

---------------------------------------------------------------------------------------------

 

These trials are being financed by the NRT shareholders and I have been able to locate a pdf report which is quite clear about the risks and possible rewards in my opinion:

 

http://messages.yahoo.com/bbs?.mm=FN&action=m&board=22689364&tid=nvgn&sid=22689364&mid=648

 

On page one, reference is made to  NOVOGEN. The latter is actually NRT but quoted on the Nasdaq. There are minimum values required and hence 1ADR=5 NVGN shares.

 

The last line of page one mentions $US 18 per ADR. Based on say $A =US 56cents, it means that one NVGN (NRT) share is: 18/ 5/ 0.56= $A6.42 against the current NRT price of  $2.18 on the AX.

 

(Yes we are losing NRT shares at the rate of 1% per month to the US investors).

 

There has been a small rise lately on the AX and it is possible that the market has moved out of the "Accumulation" phase. Presumably, some are waiting for Trial results, but it would be too early for that;  I mentioned that most of these cancers are difficult to treat.

 

Please treat that report with care. It has a Disclaimer which needs to be read. (As always, the reader is responsible for his/her Investment and not the writer of this article)

 

It gives a very good description of the compounds NRT is using and the current state of development.

 

That is my opinion,

 

Gerry

NRT Holder.

 

For after NASDAQ trading, look for NVGN:

 

 http://quotes.nasdaq.com/quote.dll?mode=stock&kind=&symbol=NVGN&symbol=LOOK&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&FormType=&mkttype=&pathname=&page=quick&selected=LOOK

 

Current price is $US 6.25 per ADR. For currencies conversions: http://www.ozforex.com.au/cgi-bin/Convert.asp